Navigation Links
Steroid Inhalers Raise Pneumonia Risk for Lung Disease Patients
Date:11/25/2008

People with chronic obstructive pulmonary disorder must weigh risks, benefits, experts say

TUESDAY, Nov. 25 (HealthDay News) -- A new review of existing data confirms that some common inhalers don't boost the life spans of people with the lung disease known as chronic obstructive pulmonary disease (COPD).

In fact, these medicines may even raise the risk of pneumonia in patients with COPD, the fourth biggest killer in the United States.

But patients shouldn't stop using the inhalers without consulting their doctors first, because the devices still provide benefit in some cases, said review lead author Dr. M. Bradley Drummond.

"It's about balancing the known benefits with potential risks," said Drummond, a fellow in the division of pulmonary and critical care medicine at Johns Hopkins University, Baltimore.

The study was published in the Nov. 26 issue of the Journal of the American Medical Association.

Chronic obstructive pulmonary disease -- which encompasses emphysema and chronic bronchitis -- follows heart disease, cancer and stroke as the leading cause of deaths among Americans, Drummond said. Symptoms include breathlessness, frequent wheezing and coughing. Treatment can ease symptoms, but there is no cure for COPD.

More than 90 percent of cases are related to smoking, Drummond said. Smoke causes abnormal inflammation in the lungs, which destroys the ends of the airways and makes it difficult for the body to extract the oxygen from the air around them, he said.

In many cases, patients can extend their lives by stopping smoking and breathing oxygen. Some turn to inhaled corticosteroids, which reduce inflammation by calming the immune system.

Inhaled corticosteroids, known by brand names such as Pulmicort, Azmacort and Flovent, are commonly used to treat lung conditions like asthma.

But research has suggested that the inhalers aren't right for all COPD patients. In the new review, Drummond and colleagues examined 11 studies and combined their results in a "meta analysis."

The researchers found no significant difference in the one-year death rate from research involving more than 4,600 patients who used the inhalers versus a similar number of patients who did not.

More patients were included in studies that examined the risk of pneumonia, however. The number of pneumonia of cases was about a third higher in those who used the inhalers compared to those who didn't.

A total of 777 of the 5,405 patients who used the inhalers developed pneumonia, compared to 561 of 5,371 patients who did not, the Johns Hopkins team noted.

Up to 15 million Americans currently have some form of COPD, Drummond said, "and it's estimated that about half of those use inhaled steroids. You're looking at six million people who may be exposed to this 34 percent increase in risk."

While there's "clearly a benefit in some patients" who report that they feel better while using inhalers, the drugs aren't for everyone, Drummond said.

It's not clear why the inhalers may boost the risks of pneumonia, he said, but they may suppress the immune system in the lungs.

Dr. Norman H. Edelman, chief medical officer of the American Lung Association, said the review reflects existing beliefs about the use of these devices

"We already have accepted that inhaled steroids increase the risk of pneumonia in COPD patients," he said. "All medication decisions involve a risk/benefit analysis. Doctors should keep the risk in mind and weigh it against actual benefits, always in full consultation with the patient, who should make the ultimate decision."

More information

There's more on COPD at the U.S. National Heart, Lung, and Blood Institute.



SOURCES: M. Bradley Drummond, M.D., fellow, division of pulmonary and critical care medicine, Johns Hopkins University, Baltimore; Norman Edelman, M.D., chief medical officer, American Lung Association, Stony Brook, N.Y.; Nov. 26, 2008, Journal of the American Medical Association


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study shows steroid therapies following transplant can be eliminated
2. Steroids aid recovery from pneumonia, UT Southwestern researchers say
3. Steroid treatment offers no benefit in preemies, Hopkins Childrens study suggests
4. Changes in sex steroids associated with menopause
5. Triax Pharmaceuticals Launches New Mid-Potency Corticosteroid Vehicle, Locoid Lotion 0.1%
6. Kids at Risk: Report Identifies 150 Websites Selling Anabolic Steroids
7. I Play Clean(TM) and Old Spice Kick Off Campaign Challenging High School Students to Pledge Against Steroid Use
8. Corticosteroids of Little Use Against Childhood Meningitis
9. ENDO 08: Latest news on hormones, steroids, obesity, diabetes and more
10. New steroid test uses oil exploration technique
11. Youth Impacted By Recent Mitchell Report on Major League Baseball Steroid Abuse
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Steroid Inhalers Raise Pneumonia Risk for Lung Disease Patients
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... ... Grocery Company to the list of fine retailers selling biodegradable, hanging flushable wipes ... H.E.B., a large supermarket chain headquartered in San Antonio, Texas, operates more than ...
(Date:4/29/2017)... , ... April 29, 2017 , ... ... the profession and recognize the positive impact veterinarians have on animal health and ... the World Organization for Animal Health (OIE) choose a theme each year and ...
(Date:4/28/2017)... ... April 28, 2017 , ... The National Campaign ... for the Access to Contraception for Women Servicemembers and Dependents Act of 2017. ... (D-CA), will help to ensure that all members of the Armed Forces receive ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... It's not ... are a number of illnesses that are unclear as to whether or not they ... heads. Bronchitis is one of these illnesses. So, FindaTopDoc took a look into the ...
(Date:4/28/2017)... City, UT (PRWEB) , ... April 28, 2017 , ... ... in some of their formulas. This begins with the popular ClearLungs Extra Strength formula. ... will be changing the formula in the following ways:, , ...
Breaking Medicine News(10 mins):
(Date:4/21/2017)... Halo Labs announces the launch of a ... called the Horizon at PEGS 2017 in ... analyzes sub visible particulate matter in biopharmaceutical samples to ... early as candidate selection and pre-formulation. Halo ... organization Elion Labs for system validation. "We ...
(Date:4/20/2017)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... it will be participating in the Deutsche Bank Securities ... in Boston, Massachusetts on Wednesday, ... a.m. Eastern Time. A live webcast of ... Relations website at http://investor.zimmerbiomet.com .  The webcast will ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Injectables Market and Increasing Usage of Complex Biologics during the Forecast ... ... USD 20 Billion in 2015 to around USD 26 Billion by ... Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex ...
Breaking Medicine Technology: